Alembic Pharmaceuticals Limited (BOM:533573)

India · Delayed Price · Currency is INR

710.45

+3.30 (0.47%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	66.72B	62.29B	56.53B	53.06B	53.93B
Pharmaceuticals Growth	7.12%	10.19%	6.54%	-1.62%	17.10%
Total	66.72B	62.29B	56.53B	53.06B	53.93B
Total Growth	7.12%	10.19%	6.54%	-1.62%	17.10%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	26.18B	24.84B	23.14B	21.21B	16.74B
India Growth	5.42%	7.36%	9.09%	26.68%	5.57%
Outside India	40.54B	37.45B	33.39B	31.11B	36.02B
Outside India Growth	8.25%	12.15%	7.33%	-13.63%	23.95%
Unallocated	-	-	-	740.00M	1.17B
Unallocated Growth	-	-	-	-36.71%	2.76%
Total	66.72B	62.29B	56.53B	53.06B	53.93B
Total Growth	7.12%	10.19%	6.54%	-1.62%	17.10%

Source: S&P Global Market Intelligence.